Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 110 of 114

  1. mexiletine

    Ultragenyx UK Limited

    Pain

    phase 3 small molecule completed

    1 trial

  2. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Disease

    phase 3 small molecule terminated

    2 trials

  3. mifepristone

    CORCEPT THERAPEUTICS INC

    Psychotic Depression

    phase 3 small molecule terminated

    1 trial

  4. mifepristone

    CORCEPT THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    5 trials

  5. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Syndrome

    phase 3 small molecule completed

    2 trials

  6. migalastat HCl 150 mg

    AMICUS THERAPEUTICS PTY LTD

    Fabry Disease

    phase 3 small molecule completed

    1 trial

  7. mipomersen

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  8. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  9. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  10. misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor Induction

    phase 3 small molecule completed

    1 trial

  11. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  12. mosapride citrate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Constipation

    phase 3 small molecule completed

    1 trial

  13. muraglitazar

    Bristol-Myers Squibb

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  14. mycophenolate mofetil (CellCept)

    Hoffmann-La Roche

    Myasthenia Gravis, Generalized

    phase 3 small molecule completed

    1 trial

  15. mycophenolate mofetil 2 g per day

    The First People's Hospital of Lianyungang

    Lymphocytic Myocarditis (Disorder)

    phase 3 small molecule completed

    1 trial

  16. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  17. nalbuphine HCl ER

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  18. nalbuphine HCl ER

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    2 trials

  19. nalbuphine HCl ER tablets 60 mg BID

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    1 trial

  20. nalbuphine HCl ER tablets 90 mg BID

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  21. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  22. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  23. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  24. nexiguran ziclumeran

    Regeneron UK Limited

    Neuromuscular Disease

    phase 3 mab active

    1 trial

  25. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    2 trials

  26. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial

  27. nomacopan (rVA576)

    Akari Therapeutics Plc

    Bullous Pemphigoid

    phase 3 small molecule terminated

    1 trial

  28. nomacopan (rVA576)

    Akari Therapeutics Plc

    Thrombotic Microangiopathies

    phase 3 small molecule terminated

    1 trial

  29. non-pegylated liposomal doxorubicin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  30. nonacog beta pegol

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    phase 3 small molecule completed

    1 trial

  31. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 other active

    1 trial

  32. nutritional supplement

    Abbott Australasia Pty Ltd

    Children

    phase 3 other completed

    1 trial

  33. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 small molecule completed

    1 trial

  34. obrixtamig

    Boehringer Ingelheim

    Small Cell Lung Cancer (SCLC)

    phase 3 small molecule active

    1 trial

  35. ofloxacin

    ABEONA THERAPEUTICS INC.

    Diabetic Foot Ulcers

    phase 3 small molecule completed

    2 trials

  36. olmesartan alone or in combination with hydrochlorothiazide

    Pfizer

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  37. omega-3-acid ethyl esters 90 (TAK-085)

    Takeda

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials

  38. one percent ultrasound power in CMICS

    Hospital Authority, Hong Kong

    Cataract

    phase 3 other active

    1 trial

  39. oral estradiol 1.0 mg

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    1 trial

  40. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  41. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  42. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  43. pagoclone

    Teva Pharma GmbH

    Stuttering

    phase 3 small molecule completed

    1 trial

  44. pantoprazole 20 mg (drug)

    Takeda

    Chronic Use of Acid Suppressive Medication

    phase 3 small molecule active

    1 trial

  45. paricalcitol

    Chinese University of Hong Kong

    IgA Nephropathy

    phase 3 small molecule terminated

    1 trial

  46. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  47. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  48. patisiran (ALN-TTR02)

    Alnylam Netherlands B.V.

    TTR-mediated Amyloidosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.